Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
12/2008
12/23/2008US7468385 Preterm labor, premature birth, dysmenorrhea, inappropriate secretion of vasopressin, congestive heart failure, arterial hypertension, liver cirrhosis, nephrotic syndrome and ocular hypertension; 3-(5-((3-chlorobenzyl)sulfanyl)-4-(3-methoxypropyl)-4H-1,2,4-triazol-3-yl)-N-(2-methoxybenzyl)propanamide
12/18/2008WO2008153858A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
12/18/2008WO2008152159A2 6 -acyloxy- 7-meth0xy- 2, 2 -dimethylchromane compounds and their use as pigmentation-regulators
12/18/2008WO2008152142A1 2 -aminoquinazoline derivatives and their therapeutic uses
12/18/2008WO2008152073A2 Piperazine compounds with a herbicidal action
12/18/2008WO2008100457A3 Functionally selective alpha2c adrenoreceptor agonists
12/18/2008US20080312451 Process For the Preparation of Sartan Derivatives and Intermediates Useful in Such Process
12/18/2008US20080312447 Process for Isolation of Crystalline Tacrolimus
12/18/2008US20080312277 Gpr41 and Modulators Thereof for the Treatment of Insulin-Related Disorders
12/18/2008DE60224400T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure
12/18/2008CA2694860A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
12/18/2008CA2689209A1 Piperazine compounds having herbicidal action
12/17/2008EP2001874A2 Docetaxel polymorphs and processes
12/17/2008EP2001872A1 Benzofuran compounds as ep1 receptor antagonists
12/17/2008EP2001849A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
12/17/2008EP2001847A2 Soluble adenylate cyclase inhibitors
12/17/2008CN101326174A Compound having hydrocoumarin skeleton, liquid crystal composition and liquid crystal display element
12/17/2008CN100443482C Benzofuran derivatives and their use in the treatment of microbial infections
12/17/2008CN100443469C 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/11/2008WO2008150486A2 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
12/11/2008WO2008150029A1 Quinolone compound and pharmaceutical composition
12/11/2008WO2008148747A2 Pdz domain modulators
12/11/2008US20080306286 Isolation, Purification and Synthesis of Procyanidin B2 and Uses Thereof
12/11/2008US20080306284 Lipase Inhibitors
12/11/2008US20080306142 Isolation, purification and synthesis of procyanidin B2 and uses thereof
12/11/2008US20080306136 Substituted Ureas and Carbamates
12/11/2008CA2688448A1 Quinolone compound and pharmaceutical composition
12/10/2008EP1999114A2 Pyrazoles as 11-beta-hsd-1
12/10/2008CN101321727A 肟酯光敏引发剂 Oxime ester photoinitiator
12/10/2008CN101318955A Method for preparing effective component of kudzu root
12/09/2008CA2326045C Pde iv inhibiting pyridine derivatives
12/04/2008WO2008147945A1 Azacyclylbenzamide derivatives as histamine-3 antagonists
12/04/2008CA2688110A1 Azacyclylbenzamide derivatives as histamine-3 antagonists
12/03/2008CN101316823A 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and MDM2 proteins for use as anticancer agents
12/03/2008CN100439374C Epothilone derivatives
12/03/2008CN100439362C Extracting and separating method of novel langdu root essence B from stellera chamaejasme L and its uses
12/03/2008CN100439357C Benzo [b][1,4] dioxepine derivatives
12/03/2008CN100439346C Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals
12/02/2008US7459480 Benzodioxepine derivatives
12/02/2008CA2248300C Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament, and pharmaceutical preparations comprising them
11/2008
11/27/2008WO2008101247A3 6 ' substituted indole and indazole derivatives having 5-ht6 receptor affinity
11/26/2008CN101311175A New xanthones compounds, preparation method and use thereof
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/25/2008US7456205 Non-insulin dependent diabetes; 7-[2-(5-methyl-2-phenyl-4-oxazole)ethoxyl]-2-oxo-2H-1-benzopyran-3-carboxylic acid methyl ester; insulin-sensitizing activities
11/25/2008US7456162 Benzofuran derivatives, their production and use
11/20/2008WO2008141130A1 Process for the preparation of epothilones
11/20/2008WO2008140828A1 Inhibitors of acetyl-coa carboxylase for treatment of neuronal hypometabolism
11/20/2008WO2008140090A1 Epoxy compound and method for manufacturing the same
11/20/2008US20080287530 Tripolide Lactone Ring Derivatives as Immunomodulators and Anticancer Agents
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008CA2686092A1 Epoxy compound and method for manufacturing the same
11/20/2008CA2685380A1 Inhibitors of acetyl-coa carboxylase for treatment of neuronal hypometabolism
11/19/2008EP1992651A1 Tertiary alcohol derivative, polymer compound and photoresist composition
11/19/2008EP1991518A2 Levulinic acid ester derivatives as reactive plasticizers and coalescent solvents
11/19/2008EP1542675A4 Compounds useful for the inhibition of aldh
11/19/2008CN101309924A Method for the preparation of escitalopram
11/18/2008CA2422379C Pyrazole compounds useful as protein kinase inhibitors
11/18/2008CA2411966C Compositions for treating or preventing malaria and method of treating malaria
11/13/2008US20080280973 Laulimalide Analogues as Therapeutic Agents
11/13/2008US20080280952 Pyridine Derivatives as Connabinoid Receptor Modulators
11/13/2008CA2685389A1 Tricyclic compounds as matrix metalloproteinase inhibitors
11/13/2008CA2680803A1 Derivatives of the aminated hydroxyquinoline class for treating cancers
11/12/2008CN101302213A Preparation of methanesulfonic acid active ester
11/12/2008CN101302212A Preparation and use of silybum marianum di-partial succinate and salt thereof
11/12/2008CN101302184A Indoline sulfanilamide compound
11/12/2008CN101302182A Virus polymerase inhibitors
11/12/2008CN100432070C Novel sulfamides and their use as endothelin receptor antagonists
11/12/2008CN100432067C Dibenzanthracene, dinaphthopyran and dibenzanthracene, dinaphtho spiropyran analog compound and its preparation
11/12/2008CN100432063C Epoxy compound, preparation method thereof, and use thereof
11/06/2008WO2008133955A1 6-phenylpyrimidinones as pim modulators
11/06/2008WO2008100456A3 Functionally selective alpha2c adrenoreceptor agonists
11/06/2008US20080275059 Novel physiologically active substances
11/06/2008US20080274094 Molecular Complex Comprising Arbutine, Ascorbic Acid, Oleuropeina or Its Derivatives Thereof and Related Uses In Medical Field
11/06/2008CA2685106A1 6-phenylpyrimidinones as pim modulators
11/05/2008EP1988075A1 Pyrrole derivative or salt thereof
11/05/2008EP1987001A1 1-phenethylpiperidine derivatives and their use as opioid receptor ligands
11/05/2008EP1200424B1 C7 heterosubstituted acetate taxanes as antitumor agents
11/05/2008CN101300244A Novel cercosporamide derivative
11/05/2008CN100430392C Carbamoyl-type benzofuran derivatives
11/04/2008US7446126 Semisynthesis process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel
10/2008
10/30/2008US20080269511 Antitumor agents; synthetic derivatives equivalent to marine polyketide derived components isolated from bryozoan Myriapora truncata
10/29/2008EP1984333A1 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
10/29/2008CN101296907A Diaminopyrimidines as P2X3 and P2X2/3 modulators
10/29/2008CN101296904A Amide derivatives as kinase inhibitors
10/28/2008USRE40558 Peroxisome proliferator-activated receptors agonists/ antagonists; 2-methyl-6-[3-(quinolin-2-ylmethoxy)-propoxymethyl]-benzoic acid; eating diorders; physiological detrimental blood level of insulin, glucose, free fatty acids, or triglycerides; hyperlipemia; atherosclerosis; antidiabetic agent
10/28/2008US7442794 Stereoisomers ; reacting with Lewis acid; purification
10/28/2008US7442793 Enzyme inhibitors as bactericides for infections and enzyme inhibitors
10/28/2008US7442705 HIV replication inhibiting pyrimidines and triazines
10/23/2008WO2008126978A1 3,4-dicarboxy-1,2,3,4-tetrahydro-6-t-butyl-1-naphthalene succinic dianhydride and liquid crystal aligning agent comprising polyimide resin prepared from the dianhydride
10/23/2008WO2008126943A2 Method for manufacturing neuraminic acid derivatives
10/23/2008WO2008125390A1 Extraction of theaflavins
10/23/2008WO2008090357A3 N, n; -substituted piperazines binding to melanocortin receptor
10/23/2008WO2008064827A3 Process for preparing nebivolol
10/23/2008US20080260685 Prodrugs of cc-1065 analogs
10/23/2008CA2783620A1 Method for manufacturing neuraminic acid derivatives
10/23/2008CA2683065A1 Method for manufacturing neuraminic acid derivatives
10/22/2008EP1981865A1 4-phenyl-3-(2-propylsulfonylamino) tetrahydrofuran derivatives which potentiate glutamate receptors and are useful in the treatment of schizophrenia
10/22/2008EP1417196B1 Dna-pk inhibitors
10/21/2008US7439265 irciniastatins, essentially pure, isolated from Indo-Pacific marine sponge Ircinia ramosa by cancer cell line bioassay-guided techniques; isochromene-pyran derivatives; dichloromethane-methanol extract; anticarcinogenic agent; P388 lymphocytic leukemia and pancreas, breast, CNS, lung cancer cell lines
10/16/2008WO2008122810A1 Phthalazinone derivatives and their use as medicament to treat cancer
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 120